Benjamin L. Schlechter, MD

Benjamin L. Schlechter, MD

Medical Oncology

Contact Information

Office Phone Number

857-215-0430

Appointments

617-632-5929

Biography

Benjamin L. Schlechter, MD

Dr. Schlechter is a medical oncologist who specializes in gastrointestinal cancers including colorectal cancer, anal cancer, pancreatic cancer, and neuroendocrine cancers, among others. He is a former intern, resident, chief resident and fellow at Beth Israel Deaconess Medical Center as well as a member of the faculty at Harvard Medical School. In the past he was the Director of Inpatient Hematology and Oncology at Beth Israel Deaconess Medical Center as well as the Assistant Program Director of the Internal Medicine Residency Program. His work at Dana-Farber focuses on providing excellent patient care while trying to advance the treatment of gastrointestinal cancer patients.

Researcher

Physician

Senior Physician
Instructor in Medicine, Harvard Medical School

Centers/Programs

Board Certification

  • Internal Medicine, 2011
  • Medical Oncology, 2014

Fellowship

  • Beth Israel Deaconess Medical Center

Residency

  • Beth Israel Deaconess Medical Center

Medical School

  • Tel Aviv University

Research

    My research interests focus on clinical innovations for patients with gastrointestinal malignancies. I am the Harvard-wide principal investigator for the PANOVA-3 clinical trial studying tumor treating fields in locally advanced pancreatic cancer; NUC-3373, a novel fluorouracil-like drug for colorectal cancer; and the ECOG EA2165 study of nivolumab after chemoradiotherapy for anal squamous cancer. I am on the Data Safety Monitoring Committees of PEN221 for advanced neuroendocrine tumors as well as AbGen107 for advanced gastrointestinal malignancies. I also have enrolled patients in multiple phase I, II, and III clinical trials for gastrointestinal malignancies. I was a lead enroller in the CATIQ phase II trial of isoquercetin to inhibit protein disulfide isomerase to prevent malignancy associated thrombosis in ambulatory cancer patients and have been an active participant in a study of fixed-dose versus weight- based enoxaparin as thromboprophylaxis for hospitalized cancer patients. In the past, I worked as a bench researcher in carcinogenesis in the laboratory of Carol Rosenberg at Boston University Medical Center and at the Wyss Institute for Biologically Inspired Engineering under the direction of Donald Ingber at HMS.

    Locations

    Location Avtar

    Dana-Farber Cancer Institute - Chestnut Hill

    300 Boylston Street Newton, MA 02459
    Get Directions
    Location Avtar

    Dana-Farber Cancer Institute

    450 Brookline Avenue Boston, MA 02215
    Get Directions
    Location Avtar

    Dana-Farber Cancer Institute - Chestnut Hill

    300 Boylston Street Newton, MA 02459
    Get Directions

    Dana-Farber Cancer Institute - Chestnut Hill

    Location Avtar

    Dana-Farber Cancer Institute - Chestnut Hill

    300 Boylston Street Newton, MA 02459
    Get Direction
    42.3192, -71.1798

    Dana-Farber Cancer Institute

    Location Avtar

    Dana-Farber Cancer Institute

    450 Brookline Avenue Boston, MA 02215
    Get Direction
    42.3374, -71.1082

    Dana-Farber Cancer Institute - Chestnut Hill

    Location Avtar

    Dana-Farber Cancer Institute - Chestnut Hill

    300 Boylston Street Newton, MA 02459
    Get Direction
    42.3192, -71.1798

    Ratings and Comments

    Benjamin L. Schlechter, MD

    About Our Ratings

    Physician Star Rating Comment Block